106
Views
2
CrossRef citations to date
0
Altmetric
CASE REPORT

Spotted leucoderma after treatment of facial hyperpigmentation on hemodialysis patients employing 1064-nm Q-switched Nd:YAG laser

, , &
Pages 47-50 | Received 14 Jun 2009, Accepted 25 Jul 2009, Published online: 23 Nov 2009

References

  • Masmoudi A, Ben Hmida M, Mseddi M, Meziou TJ, Walha N, Hachicha J, . [Cutaneous manifestations of chronic hemodialysis. Prospective study of 363 cases.] Presse Med. 2006;35(3 Pt 1):399–406.
  • Deleixhe-Mauhin F, Krezinski JM, Rorive G, Pierard GE. Quantification of skin color in patients undergoing maintenance hemodialysis. J Am Acad Dermatol. 1992;27(6 Pt 1):950–3.
  • Murakami K, Wakamatsu K, Nakanishi Y, Takahashi H, Sugiyama S, Ito S. Serum levels of pigmentation markers are elevated in patients undergoing hemodialysis. Blood Purif. 2007;25(5-6):483–9.
  • Moon SJ, Kim DK, Chang JH, Kim CH, Kim HW, Park SY, . The impact of dialysis modality on skin hyperpigmenta-tion in haemodialysis patients. Nephrol Dial Transplant. 2009 Sep;24(9):2803–9. Epub 2009 Apr 2.
  • Lai CF, Kao TW, Tsai TF, Chen HY, Huang KC, Wu MS, . Quantitative comparison of skin colors in patients with ESRD undergoing different dialysis modalities. Am J Kidney Dis. 2006;48(2):292–300.
  • Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol. 1989;93(1):28–32.
  • Shin JB, Jeong SY, Ro KW, Seo SH, Son SW, Kim IH. Sub-cellular selective photothermolysis: An electron microscopic evidence in melasma patients treated with collimated low fluence Q-switched Nd:YAG laser. Korean J Dermatol. 2008;46(S2):187–8.
  • Lin CS. Multi-center experiences of melasma treatment with low fluence Q-switched 1064-nm Nd:YAG laser (LF-QNYL) in Taiwan. 11th The Association of Korean Dermatologists Spring Symposium, 15 March 2009. 3.
  • Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, . Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146(2):228–37.
  • Shin JH, Kang WH. Two cases of melasma with unusual his-topathologic findings. J Korean Med Sci. 2006;21(2):368–70.
  • Cho SB, Park SJ, Kim JS, Kim MJ, Bu TS. Treatment of post-inflammatory hyperpigmentation using 1064-nm Q-switched Nd:YAG laser with low fluence: report of three cases. J Eur Acad Dermatol Venereol. 2009 Oct;23(10):1206–7. Epub 2009 aprill 23.
  • Glorieux G, Schepers E, Meert N, Vanholder R. Uraemic toxins in chronic kidney disease. Port J Nephrol Hypertension. 2008;22(4):287–302.
  • Schallreuter KU, Kothari S, Chavan B, Spencer JD. Regulation of melanogenesis – controversies and new concepts. Exp Dermatol. 2008;17(5):395–404.
  • Tsatmali M, Ancans J, Thody AJ. Melanocyte function and its control by melanocortin peptides. J Histochem Cytochem. 2002;50(2):125–33.
  • Spencer JD, Chavan B, Marles LK, Kauser S, Rokos H, Schallreuter KU. A novel mechanism in control of human pigmentation by β-melanocyte-stimulating hormone and 7-tetrahydrobiopterin. J Endocrinol. 2005;187(2):293–302.
  • Gotloib L, Fudin R. The impact of peritoneal dialysis upon quality of life and mortality of patients with end-stage congestive heart failure. Contrib Nephrol. 2006;150:247–53.
  • Kim MJ, Kim JS, Cho SB. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy. J Eur Acad Dermatol Venereol. 2009 Aug;23(8):960–2. Epub 2009 Jan 13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.